Beauvais DM - Search Results

1

Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progression.

Beauvais DM, Nelson SE, Adams KM, Stueven NA, Jung O, Rapraeger AC. Beauvais DM, et al. J Biol Chem. 2022 Jun;298(6):102029. doi: 10.1016/j.jbc.2022.102029. Epub 2022 May 13. J Biol Chem. 2022. PMID: 35569509 Free PMC article.

2

Syndecan-1-mediated cell spreading requires signaling by alphavbeta3 integrins in human breast carcinoma cells.

Beauvais DM, Rapraeger AC. Beauvais DM, et al. Exp Cell Res. 2003 Jun 10;286(2):219-32. doi: 10.1016/s0014-4827(03)00126-5. Exp Cell Res. 2003. PMID: 12749851

3

Syndecans in tumor cell adhesion and signaling.

Beauvais DM, Rapraeger AC. Beauvais DM, et al. Reprod Biol Endocrinol. 2004 Jan 7;2:3. doi: 10.1186/1477-7827-2-3. Reprod Biol Endocrinol. 2004. PMID: 14711376 Free PMC article. Review.

4

The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells.

Beauvais DM, Burbach BJ, Rapraeger AC. Beauvais DM, et al. J Cell Biol. 2004 Oct 11;167(1):171-81. doi: 10.1083/jcb.200404171. J Cell Biol. 2004. PMID: 15479743 Free PMC article.

5

Syndecan-1 regulates alphavbeta5 integrin activity in B82L fibroblasts.

McQuade KJ, Beauvais DM, Burbach BJ, Rapraeger AC. McQuade KJ, et al. Among authors: beauvais dm. J Cell Sci. 2006 Jun 15;119(Pt 12):2445-56. doi: 10.1242/jcs.02970. Epub 2006 May 23. J Cell Sci. 2006. PMID: 16720645

6

Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor.

Beauvais DM, Ell BJ, McWhorter AR, Rapraeger AC. Beauvais DM, et al. J Exp Med. 2009 Mar 16;206(3):691-705. doi: 10.1084/jem.20081278. Epub 2009 Mar 2. J Exp Med. 2009. PMID: 19255147 Free PMC article.

7

Syndecan-1 couples the insulin-like growth factor-1 receptor to inside-out integrin activation.

Beauvais DM, Rapraeger AC. Beauvais DM, et al. J Cell Sci. 2010 Nov 1;123(Pt 21):3796-807. doi: 10.1242/jcs.067645. J Cell Sci. 2010. PMID: 20971705 Free PMC article.

8

Vascular endothelial-cadherin stimulates syndecan-1-coupled insulin-like growth factor-1 receptor and cross-talk between αVβ3 integrin and vascular endothelial growth factor receptor 2 at the onset of endothelial cell dissemination during angiogenesis.

Rapraeger AC, Ell BJ, Roy M, Li X, Morrison OR, Thomas GM, Beauvais DM. Rapraeger AC, et al. Among authors: beauvais dm. FEBS J. 2013 May;280(10):2194-206. doi: 10.1111/febs.12134. Epub 2013 Feb 11. FEBS J. 2013. PMID: 23331867 Free PMC article.

9

Cytoplasmic domain interactions of syndecan-1 and syndecan-4 with α6β4 integrin mediate human epidermal growth factor receptor (HER1 and HER2)-dependent motility and survival.

Wang H, Jin H, Beauvais DM, Rapraeger AC. Wang H, et al. Among authors: beauvais dm. J Biol Chem. 2014 Oct 31;289(44):30318-30332. doi: 10.1074/jbc.M114.586438. Epub 2014 Sep 8. J Biol Chem. 2014. PMID: 25202019 Free PMC article.

10

Syndecan-1 (CD138) Suppresses Apoptosis in Multiple Myeloma by Activating IGF1 Receptor: Prevention by SynstatinIGF1R Inhibits Tumor Growth.

Beauvais DM, Jung O, Yang Y, Sanderson RD, Rapraeger AC. Beauvais DM, et al. Cancer Res. 2016 Sep 1;76(17):4981-93. doi: 10.1158/0008-5472.CAN-16-0232. Epub 2016 Jun 30. Cancer Res. 2016. PMID: 27364558 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters